# FDA 483 - Giora Weisz MD - October 24, 2019

Source: https://www.globalkeysolutions.net/records/483/giora-weisz-md/20c8a88f-acb4-413a-a13f-98d6f7fd4a91

> FDA 483 for Giora Weisz MD on October 24, 2019. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Giora Weisz MD
- Inspection Date: 2019-10-24
- Product Type: drugs
- Office Name: New York District Office
- Summary: An FDA inspection of Giora Weisz MD in Bronx, NY, identified a significant deviation from the investigational plan. The firm failed to adhere to protocol for scheduled laboratory assessments and did not properly follow exclusion criteria for study subjects. This indicates a lack of compliance with established clinical trial procedures.

## Related Officers

- [investigator](https://www.globalkeysolutions.net/people/iram-r-hassan/f62a86e8-20bc-4446-ade0-17b5f67ad386)

Company: https://www.globalkeysolutions.net/companies/giora-weisz-md/a4cec78b-62b6-4b91-8a51-a1312224680b

Office: https://www.globalkeysolutions.net/offices/new-york-district-office/9fa3d265-16ca-438d-8a6e-b47f60dc260d